Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Houda Alachkar

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 21, 2024
Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99 nanoparticle treatmentShephali Kadam, Atham Ali, Mateusz Pospiech, et al.
Frontiers in Immunology|November 6, 2023
Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemiaMateusz Pospiech, Mukund Tamizharasan, Yu-Chun Wei, et al.
Cellular & Molecular Biology Letters|May 24, 2023
Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironmentYiting Meng, Mateusz Pospiech, Atham Ali, et al.
International Immunopharmacology|June 25, 2024
The DNA methylation landscape across the TCR loci in patients with acute myeloid leukemiaMateusz Pospiech, John Beckford, Advaith Maya Sanjeev Kumar, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 6, 2023
Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understandingAmani Alqahtani, Diala Alhousari, Amir Ali, et al.
Journal of Medical Cases|January 5, 2026
Acute Myeloid Leukemia With a Non-Canonical <i>FLT3</i> V491L Mutation: A Case Report With <i>Ex Vivo</i> FLT3 Inhibitors Sensitivity TestingMateusz Pospiech, Michelle P Ngo, Misk Alrawashdeh, et al.
Oncotarget|November 21, 2015
SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cellsTheodore Vougiouklakis, Kenbun Sone, Vassiliki Saloura, et al.
Cancer Research Communications|July 15, 2024
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid LeukemiaAtham Ali, Alvin Phan, Vijaya Vaikari, et al.
Translational Oncology|October 27, 2015
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)Martin Mutonga, Kenji Tamura, Gregory Malnassy, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 31, 2023
Prediction of Peptide and TCR CDR3 Loops in Formation of Class I MHC-Peptide-TCR Complexes Using Molecular Models with SolvationNairuti Milan Mehta, Yuhui Li, Vini Patel, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 21, 2024
Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99 nanoparticle treatmentShephali Kadam, Atham Ali, Mateusz Pospiech, et al.
Frontiers in Immunology|November 6, 2023
Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemiaMateusz Pospiech, Mukund Tamizharasan, Yu-Chun Wei, et al.
Cellular & Molecular Biology Letters|May 24, 2023
Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironmentYiting Meng, Mateusz Pospiech, Atham Ali, et al.
International Immunopharmacology|June 25, 2024
The DNA methylation landscape across the TCR loci in patients with acute myeloid leukemiaMateusz Pospiech, John Beckford, Advaith Maya Sanjeev Kumar, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 6, 2023
Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understandingAmani Alqahtani, Diala Alhousari, Amir Ali, et al.
Journal of Medical Cases|January 5, 2026
Acute Myeloid Leukemia With a Non-Canonical <i>FLT3</i> V491L Mutation: A Case Report With <i>Ex Vivo</i> FLT3 Inhibitors Sensitivity TestingMateusz Pospiech, Michelle P Ngo, Misk Alrawashdeh, et al.
Oncotarget|November 21, 2015
SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cellsTheodore Vougiouklakis, Kenbun Sone, Vassiliki Saloura, et al.
Cancer Research Communications|July 15, 2024
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid LeukemiaAtham Ali, Alvin Phan, Vijaya Vaikari, et al.
Translational Oncology|October 27, 2015
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)Martin Mutonga, Kenji Tamura, Gregory Malnassy, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 31, 2023
Prediction of Peptide and TCR CDR3 Loops in Formation of Class I MHC-Peptide-TCR Complexes Using Molecular Models with SolvationNairuti Milan Mehta, Yuhui Li, Vini Patel, et al.
Pageof 6